News

AIM Vaccine Co., Ltd. has received approval from the National Medical Products Administration for ... significant ...
Breakthrough approval highlights the power of AIM’s next-gen platform and global ambition in biotech innovation.
These Cepas are "connecting exporters to global opportunities and creating platforms for joint ventures and private sector collaboration”, Dr Al Zeyoudi said. The 2025 Aim Congress is expected ...